Prof. Dr Arif has been the CEO of Al Qassimi Hospital Sharjah – UAE (Since  2009), Head of Cardiac Cath Lab at Al Qassimi Hospital Sharjah – UAE  (since 2004) & Head of Cardiac Centre (since 2012). He is the Member  of National Committee with the objective of reduction of Mortality from  the cardiovascular disease on National Level, under the Emirates  National vision 2021 (since May 2016). He is also the Associate  Professor of Cardiology at University of Sharjah (since Sept 2018), PhD  studies in Cardiovascular Medicine, Medical faculty, University of  Belgrade, Serbia (since 2018)

Dr. Arif is a member of the Emirates Cardiac Society – Head of the  Interventional Cardiology (since March 2016), Emirates Medical  Association & Royal College of Physicians & Surgeons of Glasgow  since 2013. He was the National Coordinator for UAE – European  Association of Percutaneous Cardiovascular Interventions (EAPCI).

Dr. Arif is an official reviewer in International Journals such as  Catheterization and Cardiovascular Interventions, Ex Reviewer – Elsevier  Journals & Editorial board member for journal Cardiology Cases and  Systematic Reviews (CCSR). Dr.Arif is fluent in Arabic, English, German  and Urdu.

Area of Expertise

• Interventional Cardiology with Management of CTO’s & Complex PCI’s

• Coronary Imaging

• Rotablation, Laser, Shockwave & Orbital Atherectomy.

• Reperfusion Therapy Strategies

• BRS Implantation

• Structural Heart Disease (TAVI & Mitral Clip)

• Left Atrial Appendage (LAA) Occluders

• Robotically Assisted PCI’s (Corindus)

• Pathophysiology of acute coronary syndromes

Education

• B.B.S. from the College of Medicine and Medical Sciences), ULM-Germany

• German Board of Internal Medicine Certification

• German Board Cardiology Certification

Publications

• Arif A. Al Nooryani1 , Nagwa A. Abdelrahman1,2*, Hatem A. Helmy2 ,  Yehia T. Kishk2 and Ayman K. M. Hassan2 The role of optical coherence  tomography guidance in scaffold versus stent optimization The Egyptian  Heart Journal (2020) 72:77 https://doi.org/10.1186/s43044-020-00110-Z

• Al-Nooryani A, Aboushokka W, Mehmedbegovic Z, Beleslin B. A case of  mild-tointermediate left-main lesion with high-risk plaque features:  “Blindness of physiology” for PCI guidance?. Clin Case Rep. 2020;00:1–5  https://doi.org/10.1002/ccr3.3197

• Arif Al-Nooryani1*, Wael Aboushokka1 , Zlatko Mehmedbegovic2,3,  Branko Beleslin 2,3 Very late coronary thrombosis following  bioresorobable vascular scaffold implantation for spontaneous coronary  artery dissection Interventional-Cardiology.1000644 © 2020 ISSN  1755-5302 Interventional Cardiology Case Report Interv. Cardiol. (2020)  12(1), 13-16

• Al Nooryani A, Elabbassi WN, AlBaba B, Jalal JA, Abudaqa LM, Bhatia  A, Abdelrahman NA, Boskovic N, Beleslin B. Long-term outcome of first  300 implanted Absorb bioresorbable vascular in an all-comers Middle East  population. J Int Med Researsh 2018; in press. DOI:  10.1177/0300060518798994

• Al Nooryani A, Abdalla GA, Ghafar TA, Bhatia A, Beleslin B.  Implantation of bioresorbable vascular scaffold for the treatment of  pudendal artery stenosis and erectile deysfunction. Andrologia 2018; in  press. DOI: 10.1111/and.13153

• Nooryani A, Elabbassi W, Markovic M, Dobric M, Beleslin B.  Robotic-Assisted complete functional myocardial revascularization using  bioresorbable bascular scaffolds. J Intervent Cardiology 2015;1:5

• Darren Mylotte, MD,a Arnaud Sudre, MD,b Emmanuel Teiger, MD, PHD,c  Jean François Obadia, MD, PHD,d Marcus Lee, MD, Mark Spence, MD,e Hazem  Khamis, MD,f Arif Al Nooryani, MD,g Cedric Delhaye, MD,b Gilles Amr,  MD,b Mohamad Koussa, MD,b Nicolas Debry, MD,b Nicolo Piazza, MD, PHD,h  Thomas Modine, MD, PHDb Transcarotid Transcatheter Aortic Valve  Replacement VOL. 9, NO. 5, 20 1 6 by the American College of Cardiology  Foundation Issue SN 1 9 3 6 – 8 7 9 8

• Elabbassia W, Al Ailaa F, Chowdhuryb MA, Najiba A, Zaidc H,  Michelinc M, Al Nooryani A. The impact of severity of initial illness,  determined by SOFA score, and presence of anemia on outcomes among  patients requiring Extra Corporal Membrane Oxygenation (ECMO) support: A  single center experience: Indian Heart J 2017; 69:762-766.

• Abudaqa L, Hayder A, Al Nooryani A, Elabbassi W. Acute inferior  myocardial Infarction in a young female: Initial presentation of  Takayasu arteritis. 2016:
  DOI: 10.4172/2329-9495.1000180 ResearchGate

• Elabbassi W, Al Nooryani Skirt followed by trouser stenting  technique: True anatomical preservation of coronary Y-shaped bifurcation  lesions while using“vanishing” bioresorbable scaffolds: A report of two  cases: Cardiovascular Revascularization Medicine 18 (2017) 281–286.

• Elabbassi W, Osman AN, Chowdhury MA, Al Nooryani A. Device-related  thrombus overlying a left-atrial occlusion device implanted for  persistent spontaneous echo contrast despite prolonged oral  anticoagulation therapy. Cardiology 2013;125(2):78-81.

• Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S,  Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick  A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators. The  sirolimus-eluting Cypher Select coronary stent for the treatment of  bare-metal and drug-eluting stent restenosis: insights from the e-SELECT  (Multicenter Post-Market Surveillance) registry. JACC Cardiovasc Interv  2012;5(1):64-71

• Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V,  Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M,  Spaulding C, Worthley S; e-SELECT Investigators. Stent thrombosis and  bleeding complications after implantation of sirolimus-eluting coronary  stents in an unselected worldwide population: a report from the e-SELECT  (Multi-Center Post-Market Surveillance)registry. J Am CollCardiol.  2011;57(13):1445-54